Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma
JAMA · 24.09.2024 · 332 (12) · 1013
DOI: 10.1001/jama.2024.14101 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA, erschienen am 24.09.2024. Verfasst von Sarah Park und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, Illinois. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Practice Guidelines as Topic. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
This JAMA Clinical Guidelines Synopsis summarizes the 2023 American Association for the Study of Liver Diseases practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Hepatology, and Nutrition, University of Chicago Medicine, Chicago, Illinois.
- Department of Internal Medicine, University of Chicago Medicine, Chicago, Illinois.
Zitieren
APA
Park, S., Davis, A. M., & Pillai, A. A. (2024). Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA, 332(12), 1013. https://doi.org/10.1001/jama.2024.14101
Vancouver
Park S, Davis AM, Pillai AA. Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma. JAMA. 2024;332(12):1013. doi:10.1001/jama.2024.14101
BibTeX
@article{Park2024,
author = {Park, Sarah and Davis, Andrew M and Pillai, Anjana A},
title = {Prevention, Diagnosis, and Treatment of Hepatocellular Carcinoma},
journal = {JAMA},
year = {2024},
volume = {332},
number = {12},
pages = {1013},
doi = {10.1001/jama.2024.14101}
}
EUVIMED